Lv0
0 积分 2023-11-30 加入
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
1年前
已完结
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry
1年前
已完结
Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract
1年前
已完结
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials
1年前
已完结
Investigation of eligibility for adjuvant therapy from real-world data of patients with urothelial carcinoma undergoing radical cystectomy and radical nephroureterectomy
1年前
已完结
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma
1年前
已完结
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment
1年前
已完结
Progress in systemic therapy for advanced-stage urothelial carcinoma
1年前
已完结
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment
1年前
已完结
Prostate cancer as a chronic disease: cost-effectiveness and proper follow-up
1年前
已关闭
皖公网安备34019202002308
